A multicenter randomized trial of two different proMACE-cytaBOM derived protocols in aggressive non-hodgkin's lymphomas (NHL). A preliminary report

M. Carotenuto, M. Federico, P. Avanzini, L. Baldini, M. Brugiatelli, L. Cavanna, N. di Renzo, P. G. Gobbi, V. Iannitto, A. La Sala, M. Lombardo, G. Longo, F. Narni, G. Nicoletti, V. Silingardi, C. Mauri

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalLeukemia and Lymphoma
Volume7
Issue numberS2
DOIs
Publication statusPublished - 1992

Keywords

  • Aggressive lymphomas
  • Multicenter trial
  • PROMACE-CYTABOM

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Carotenuto, M., Federico, M., Avanzini, P., Baldini, L., Brugiatelli, M., Cavanna, L., di Renzo, N., Gobbi, P. G., Iannitto, V., Sala, A. L., Lombardo, M., Longo, G., Narni, F., Nicoletti, G., Silingardi, V., & Mauri, C. (1992). A multicenter randomized trial of two different proMACE-cytaBOM derived protocols in aggressive non-hodgkin's lymphomas (NHL). A preliminary report. Leukemia and Lymphoma, 7(S2), 25-28. https://doi.org/10.3109/10428199209058649